CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 64 enrolled
Drug / intervention
bupivacaine wound infilteration +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06531603
NCT06531603Phase 3Completed

Comparison of Postoperative Analgesic Effectiveness of Bupivacaine and Bupivacaine Plus Dexmedetomidine Wound Infiltration in Abdominal Surgeries Under General Anesthesia

Sahiwal medical college sahiwal·interventional·Posted Aug 1, 2024·Updated Aug 1, 2024

In Brief

A Phase 3 clinical trial evaluating bupivacaine wound infilteration and Bupivacaine plus dexmedetomidine wound infilteration for Post Operative Pain and 4 related conditions. Completed, enrolled 64 participants across 1 site.

Detailed Summary

Abdominal surgeries are major surgical procedures that are performed at any teaching hospital. Pain control is major concern in the intra-operative as well as post-operative period in these patients. Optimal pain control in post-operative period is directly related to patient's recovery, shortens the patients' hospital stay and overall burden on health facilities. Inadequate pain control may affect quality of life and increases patient's morbidity and mortality. Different modalities for pain control are used in post-operative period. Opioids are mainstay of treatment in post-operative period but historically are associated with significant side effect profile like dependence, nausea, vomiting, respiratory depression, constipation and many others. Dexmedetomidine is centrally acting α-2 adrenoceptor agonist.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesPakistan
Collaborators--

Timeline

Phase 3CompletedFinished
2023202420252026
First PostedAug 1, 2024
Enrollment StartFeb 20, 2022
Primary CompletionJan 20, 2023
Study CompletionApr 20, 2023
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 1.9 years ago

Interventions

bupivacaine wound infilterationdrug

drug was given at the end of surgery

Bupivacaine plus dexmedetomidine wound infilterationdrug

drug was given at the end of surgery